3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment
Cellular Oncology · 2024-08 · 47 (4) · 1113-1126
DOI: 10.1007/s13402-024-00935-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 23.03.2024. Verfasst von Zhanyi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bethune Third Clinical Medical College, Jilin University, Changchun, 130021, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Printing, Three-Dimensional, Bioprinting, Immunotherapy. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Health Research Talent Special Project.
Abstract (Originalsprache)
Background Cancer immunotherapy is receiving worldwide attention for its induction of an anti-tumor response. However, it has had limited efficacy in some patients who acquired resistance. The dynamic and sophisticated complexity of the tumor microenvironment (TME) is the leading contributor to this clinical dilemma. Through recapitulating the physiological features of the TME, 3D bioprinting is a promising research tool for cancer immunotherapy, which preserves in vivo malignant aggressiveness, heterogeneity, and the cell–cell/matrix interactions. It has been reported that application of 3D bioprinting holds potential to address the challenges of immunotherapy resistance and facilitate personalized medication. Conclusions and Perspectives In this review, we briefly summarize the contributions of cellular and noncellular components of the TME in the development of immunotherapy resistance, and introduce recent advances in 3D bioprinted tumor models that served as platforms to study the interactions between tumor cells and the TME. By constructing multicellular 3D bioprinted tumor models, cellular and noncellular crosstalk is reproduced between tumor cells, immune cells, fibroblasts, adipocytes, and the extracellular matrix (ECM) within the TME. In the future, by quickly preparing 3D bioprinted tumor models with patient-derived components, information on tumor immunotherapy resistance can be obtained timely for clinical reference. The combined application with tumoroid or other 3D culture technologies will also help to better simulate the complexity and dynamics of tumor microenvironment in vitro. We aim to provide new perspectives for overcoming cancer immunotherapy resistance and inspire multidisciplinary research to improve the clinical application of 3D bioprinting technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bethune Third Clinical Medical College, Jilin University, Changchun, 130021, China.
- Department of Gastrointestinal, Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, NO. 126, Xiantai Street, Changchun, 130033, China.
- Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.
- Department of Gastrointestinal, Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, NO. 126, Xiantai Street, Changchun, 130033, China. fangxd@jlu.edu.cn.
- Department of Breast Surgery, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, NO. 519, Kunzhou Street, Kunming, 650118, China. renshengnan@j…
Förderung
- Jilin Province Health Research Talent Special Project
Zitieren
APA
Zhang, Z., Chen, X., Gao, S., Fang, X., & Ren, S. (2024). 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment. Cellular Oncology, 47(4), 1113-1126. https://doi.org/10.1007/s13402-024-00935-9
Vancouver
Zhang Z, Chen X, Gao S, Fang X, Ren S. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment. Cellular Oncology. 2024;47(4):1113-1126. doi:10.1007/s13402-024-00935-9
BibTeX
@article{Zhang2024,
author = {Zhang, Zhanyi and Chen, Xuebo and Gao, Sujie and Fang, Xuedong and Ren, Shengnan},
title = {3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment},
journal = {Cellular Oncology},
year = {2024},
volume = {47},
number = {4},
pages = {1113--1126},
doi = {10.1007/s13402-024-00935-9}
}
EUVIMED